Form 4 for EDIT Editas Medicine, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-02 · accession 0001650664-24-000019 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-03-05 | 2024-03-02 | EDIT | Lucera Erick | EVP, CFO | A - Grant | $0.00 | +61.3K | 139.2K | +79% | $0 |
| D | 2024-03-05 | 2024-03-02 | EDIT | Lucera Erick | EVP, CFO | A - Grant | $0.00 | +106.0K | 106.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-02 | A | A | 35,300 | $0.00 | 113,200 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-02 | A | A | 25,966 | $0.00 | 139,166 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-03-02 | A | A | 106,000 | $0.00 | 106,000 | D | $10.53 · — to 2034-03-01 | 106,000 Common Stock | (F3) This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on April 2, 2024 through March 2, 2028. |